New research from the University of Adelaide has shown for the first time that the growth of brain tumors can be halted by a drug currently being used to help patients recover from the side effects of chemotherapy. The discovery has been made during a study looking at the relationship between brain tumors and a peptide associated with inflammation in the brain, called “substance P.”
